Therapeutic Potential of Glycosyl Flavonoids as Anti-Coronaviral Agents
The COVID-19 pandemic, caused by <i>severe acute respiratory syndrome coronavirus 2</i> (SARS-CoV-2), has spread all over the world, creating a devastating socio-economic impact. Even though protective vaccines are starting to be administered, an effective antiviral agent for the prevent...
Main Authors: | Patrícia I. C. Godinho, Raquel G. Soengas, Vera L. M. Silva |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/6/546 |
Similar Items
-
Microbial Glycosylation of Flavonoids
by: Sandra Sordon, et al.
Published: (2016-06-01) -
Progress and Achievements in Glycosylation of Flavonoids
by: Ruslana S. Khodzhaieva, et al.
Published: (2021-03-01) -
Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro
by: Seri Jo, et al.
Published: (2020-01-01) -
The role of the glycosyl moiety of myricetin derivatives in anti-HIV-1 activity in vitro
by: Joseph T. Ortega, et al.
Published: (2017-10-01) -
Anti-viral and anti-inflammatory effects of kaempferol and quercetin and COVID-2019: A scoping review
by: Mohammad Reza Khazdair, et al.
Published: (2021-01-01)